Literature DB >> 18208925

Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.

P van Ruitenbeek1, A Vermeeren, Wj Riedel.   

Abstract

Results from recent animal studies suggest an important role for histamine in memory functioning. Histaminergic drugs might prove beneficial for people suffering from memory impairment. To determine if histamine is involved in memory functioning this study evaluates the effects of histaminergic dysfunction on memory performance by administrating a H1-antagonist to humans. The study was conducted according to a 4-way, double-blind, crossover design in 20 healthy female volunteers, aged 18-45 years. On each test day subjects completed three test sessions: before and around 2 and 4 h after administration of single oral doses of dexchlorpheniramine 2 mg or 4 mg, scopolamine 1 mg or placebo. Drug effects were assessed using tests of memory, psychomotor and attention performance, and subjective alertness. Results showed that dexchlorpheniramine impaired performance in tests of spatial learning, reaction time, tracking and divided attention but showed no effects on working memory, visual memory, word learning or memory scanning. Scopolamine induced a similar pattern of effects. In addition, both drugs decreased subjective alertness. In conclusion results show that dexchlorpheniramine and scopolamine clearly impaired performance on psychomotor and attention tasks but do not suggest a specific role of the histaminergic system in learning and memory in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208925     DOI: 10.1177/0269881107081526

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  9 in total

1.  An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.

Authors:  Anne Catrien Baakman; Ricardo Alvarez-Jimenez; Robert Rissmann; Erica S Klaassen; Jasper Stevens; Sebastiaan C Goulooze; Jeroen C G den Burger; Eleonora L Swart; Joop M A van Gerven; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2017-04-08       Impact factor: 4.335

2.  Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory.

Authors:  P van Ruitenbeek; A Vermeeren; W J Riedel
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram.

Authors:  Anke Sambeth; Wim J Riedel; Inge Klinkenberg; Seppo Kähkönen; Arjan Blokland
Journal:  Psychopharmacology (Berl)       Date:  2014-12-04       Impact factor: 4.530

4.  Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.

Authors:  P van Ruitenbeek; A Vermeeren; F T Y Smulders; A Sambeth; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

5.  The role of P-glycoprotein in CNS antihistamine effects.

Authors:  Silke Conen; Eef L Theunissen; Annemiek Vermeeren; Peter van Ruitenbeek; Peter Stiers; Mitul A Mehta; Stefan W Toennes; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2013-04-07       Impact factor: 4.530

6.  Effects of L-histidine depletion and L-tyrosine/L-phenylalanine depletion on sensory and motor processes in healthy volunteers.

Authors:  P van Ruitenbeek; A Sambeth; A Vermeeren; S N Young; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

7.  Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.

Authors:  Arjan Blokland; Anke Sambeth; Jos Prickaerts; Wim J Riedel
Journal:  Front Neurol       Date:  2016-09-30       Impact factor: 4.003

8.  The Usage of Histamine Type 1 Receptor Antagonist and Risk of Dementia in the Elderly: A Nationwide Cohort Study.

Authors:  Chuan-Chi Yang; Wu-Chien Chien; Chi-Hsiang Chung; Chung-Yu Lai; Nian-Sheng Tzeng
Journal:  Front Aging Neurosci       Date:  2022-03-18       Impact factor: 5.750

9.  Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis.

Authors:  Pengxiang Zhou; Qiong Jia; Zhenhuan Wang; Rongsheng Zhao; Wei Zhou
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.